The Technical Analyst
NantHealth Inc [NH]
Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
NantHealth Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $1.350
America/New_York / 4 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 10.40 mill |
| EPS: | -11.40 |
| P/E: | -0.120 |
| Earnings Date: | Aug 02, 2023 |
| SharesOutstanding: | 7.70 mill |
| Avg Daily Volume: | 0 mill |
| RATING 2023-05-23 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Sell | |
| DE: | Strong Sell | |
| P/E: | Neutral | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -0.120 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -0.120 | industry: PE -4.88 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 1.047 - 1.653 ( +/- 22.44%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2023-09-16 | Naseem Rao Haris | Buy | 1 000 000 | Stock Option (Right to Buy) |
| 2023-09-07 | Naseem Rao Haris | Buy | 0 | Common Stock |
| 2023-08-28 | Summus Holdings Llc | Sell | 0 | Common Stock |
| 2023-08-28 | Soon-shiong Patrick | Buy | 537 272 | Common Stock |
| 2023-08-28 | Soon-shiong Patrick | Buy | 15 384 616 | Common Stock |
| INSIDER POWER |
|---|
| 100.00 |
| Last 97 transactions |
| Buy: 88 503 201 | Sell: 27 090 358 |
Forecast:
01:40 - $1.733
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.350 (0.00% ) |
| Volume | 0.198 mill |
| Avg. Vol. | 0 mill |
| % of Avg. Vol | 0 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For NH
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
NH
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform's comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans and CMS for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks. In addition, it offers Quadris, a data solution that includes multi-data analysis, reporting, and professional services. The company was formerly known as Nant Health, LLC and changed its name to NantHealth, Inc. in June 2016. The company was incorporated in 2010 and is headquartered in Morrisville, North Carolina. NantHealth, Inc. is as a subsidiary of NantWorks, LLC.
Latest Press Releases
2024-04-10 09:00:00 - Press Release
Nanthealth Strengthens Product Leadership Team To Drive Innovation In Healthcare Technology
Winterville, n.c.--(business wire)--nanthealth, inc. (nasdaq-gs: nh), proudly announces the expansion of its product leadership team by appointing three seasoned executives who will spearhead efforts to integrate innovation, automation, and artificial intelligence into the company's product offerings. this strategic move underscores nanthealth's unwavering commitment to revolutionizing healthcare technology and delivering excellence to its customers. keith krebs - senior vice president and gene.
2022-10-31 16:50:00 - Press Release
Nanthealth To Report 2022 Third-quarter Financial Results And Host Conference Call On Thursday, November 3
Morrisville, n.c.
2022-08-01 06:53:00 - Press Release
Nanthealth To Report 2022 Second-quarter Financial Results And Host Conference Call On Thursday, August 4
Morrisville, n.c.--(business wire)--nanthealth, inc. (nasdaq-gs: nh), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 second quarter on thursday, august 4, 2022, after market close. nanthealth management will host a conference call that same day at 1:30 p.m. pt (4:30 p.m. et) to review the company’s performance. the conference call will be available to interested parties by dialing 800-771-6692 from the u.s. or canada, or 212-231-2907 from international locations. the call will be broadcast via the internet at www.nanthealth.com. about nanthealth, inc. nanthealth, a member of the nantworks ecosystem of companies, provides enterprise solutions that help businesses transform complex data into actionable insights...
2022-05-02 06:53:00 - Press Release
Nanthealth To Report 2022 First-quarter Financial Results And Host Conference Call On Thursday, May 5
Morrisville, n.c.--(business wire)--nanthealth, inc. (nasdaq-gs: nh), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 first quarter on thursday, may 5, 2022, after market close. nanthealth management will host a conference call that same day at 1:30 p.m. pt (4:30 p.m. et) to review the company’s performance. the conference call will be available to interested parties by dialing 800-920-5526 from the u.s. or canada, or 212-231-2907 from international locations. the call will be broadcast via the internet at www.nanthealth.com. about nanthealth, inc. nanthealth, a member of the nantworks ecosystem of companies, provides enterprise solutions that help businesses transform complex data into actionable insights...
2022-02-18 06:53:00 - Press Release
Nanthealth To Report 2021 Fourth-quarter, Full-year Financial Results And Host Conference Call On Thursday, February 24
Morrisville, n.c.--(business wire)--nanthealth, inc. (nasdaq-gs: nh), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2021 fourth quarter and full year on thursday, february 24, 2022, after market close. nanthealth management will host a conference call that same day at 1:30 p.m. pt (4:30 p.m. et) to review the company’s performance. the conference call will be available to interested parties by dialing 877-407-0312 from the u.s. or canada, or 201-389-0899 from international locations. the call will be broadcast via the internet at www.nanthealth.com. about nanthealth, inc...
Latest News
2022-11-06 07:04:04 - Seeking Alpha
NantHealth, Inc. (NH) Q3 2022 Earnings Call Transcript
NantHealth, Inc. (NASDAQ:NH ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Ron Louks - Chief Operating Officer Bob Petrou - Chief Financial Officer Conference Call Participants Robert Jaffe Welcome everyone and thank you for joining us today to discuss NantHealth's 2022 Third Quarter Financial Results. On the call today are Ron Louks, Chief Operating Officer; and Bob Petrou, our Chief Financial Officer.
2022-10-31 16:50:00 - Business Wire
NantHealth to Report 2022 Third-Quarter Financial Results and Host Conference Call on Thursday, November 3
2022-08-06 18:45:17 - Seeking Alpha
NantHealth, Inc. (NH) Management on Q2 2022 Results - Earnings Call Transcript
NantHealth, Inc. (NASDAQ:NH ) Q2 2022 Earnings Conference Call August 4, 2022 4:30 PM ET Company Participants Robert Jaffe - Investor Relations Ron Louks - Chief Operating Officer Bob Petrou - Chief Financial Officer Robert Jaffe Welcome, everyone, and thank you for joining us today to discuss NantHealth's 2022 second quarter financial results. On the call today are Ron Louks, Chief Operating Officer; and Bob Petrou, our Chief Financial Officer.
2022-05-08 03:30:04 - Seeking Alpha
NantHealth's (NH) Management on Q1 2022 Results - Earnings Call Transcript
NantHealth, Inc. (NASDAQ:NH ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Robert Jaffe – Investor Relations Ron Louks – Chief Operating Officer Bob Petrou – Chief Financial Officer Conference Call Participants Robert Jaffe Welcome, everyone, and thank you for joining us today to discuss NantHealth's 2022 First Quarter Financial Results. On the call today are Ron Louks, Chief Operating Officer; and Bob Petrou, our Chief Financial Officer.
2022-02-27 10:16:03 - Seeking Alpha
NantHealth, Inc. (NH) Q4 2021 Results - Earnings Call Transcript
2022-02-24 20:46:22 - Zacks Investment Research
NantHealth, Inc. (NH) Reports Q4 Loss, Tops Revenue Estimates
NantHealth, Inc. (NH) delivered earnings and revenue surprises of -11.11% and 0.19%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
2021-11-04 22:05:41 - Zacks Investment Research
NantHealth, Inc. (NH) Reports Q3 Loss, Misses Revenue Estimates
NantHealth, Inc. (NH) delivered earnings and revenue surprises of -25.00% and -18.88%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
2021-09-29 08:00:00 - Business Wire
NantHealth's Chief Medical Officer to Educate on Advancing Equity in Cancer Care at the Oncology Clinical Pathways Congress 2021
EL SEGUNDO, Calif.--(BUSINESS WIRE)--NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that Dr. Tiffany Avery, Chief Medical Officer, was selected to present a continuing education session at the Oncology Clinical Pathways Congress 2021. Dr. Avery's session, titled Utilizing Pathways to Advance Equity in Cancer Care, will take place virtually on Friday, October 1, 2021, and cover how clinical p
2021-08-05 22:50:43 - Seeking Alpha
NantHealth, Inc. (NH) Management on Q2 2021 Results - Earnings Call Transcript
2021-08-05 20:32:16 - Zacks Investment Research
NantHealth, Inc. (NH) Reports Q2 Loss, Lags Revenue Estimates
NantHealth, Inc. (NH) delivered earnings and revenue surprises of 20.00% and -5.35%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?